<s id="wsj_1156.1"> 35
2 	 0 	 N/N 	 1 	 Johnson Johnson
2 	 1 	 N/N 	 1 	 Johnson &
2 	 3 	 (S[dcl]\NP)/NP 	 1 	 Johnson reported
6 	 5 	 (N/N)/(N/N) 	 2 	 % 10
7 	 3 	 (S[dcl]\NP)/NP 	 2 	 rise reported
7 	 4 	 NP[nb]/N 	 1 	 rise a
7 	 6 	 N/N 	 1 	 rise %
7 	 8 	 (NP\NP)/NP 	 1 	 rise in
7 	 12 	 (NP\NP)/NP 	 1 	 rise on
7 	 18 	 (NP\NP)/NP 	 1 	 rise -
11 	 8 	 (NP\NP)/NP 	 2 	 income in
11 	 9 	 N/N 	 1 	 income third-quarter
11 	 10 	 N/N 	 1 	 income net
17 	 12 	 (NP\NP)/NP 	 2 	 increase on
17 	 13 	 NP[nb]/N 	 1 	 increase a
17 	 14 	 N/N 	 1 	 increase 12
17 	 15 	 N/N 	 1 	 increase %
17 	 16 	 N/N 	 1 	 increase sales
19 	 18 	 (NP\NP)/NP 	 2 	 results -
19 	 20 	 (NP\NP)/(S[dcl]\NP) 	 1 	 results that
19 	 21 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 results were <XB>
19 	 22 	 S[pss]\NP 	 1 	 results driven <XB>
21 	 20 	 (NP\NP)/(S[dcl]\NP) 	 2 	 were that
22 	 21 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 driven were
22 	 24 	 ((S\NP)\(S\NP))/NP 	 2 	 driven by
24 	 23 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 by particularly
26 	 24 	 ((S\NP)\(S\NP))/NP 	 3 	 products by
26 	 25 	 N/N 	 1 	 products new
26 	 27 	 (NP\NP)/NP 	 1 	 products including
28 	 27 	 (NP\NP)/NP 	 2 	 pharmaceuticals including
31 	 30 	 NP[nb]/N 	 1 	 company the
31 	 32 	 (NP[nb]/N)\NP 	 2 	 company 's
34 	 27 	 (NP\NP)/NP 	 2 	 operations including
34 	 32 	 (NP[nb]/N)\NP 	 1 	 operations 's
34 	 33 	 N/N 	 1 	 operations professional
<\s>
<s id="wsj_1156.2"> 39
0 	 1 	 (NP\NP)/NP 	 1 	 Net for
0 	 12 	 S[dcl]\NP 	 1 	 Net climbed
4 	 3 	 (N/N)/(N/N) 	 2 	 Brunswick New
8 	 1 	 (NP\NP)/NP 	 2 	 maker for
8 	 2 	 NP[nb]/N 	 1 	 maker the
8 	 4 	 N/N 	 1 	 maker Brunswick <XU>
8 	 6 	 N/N 	 1 	 maker N.J.
8 	 9 	 (NP\NP)/NP 	 1 	 maker of
11 	 9 	 (NP\NP)/NP 	 2 	 products of
11 	 10 	 N/N 	 1 	 products health-care
12 	 13 	 ((S\NP)\(S\NP))/NP 	 2 	 climbed to
12 	 24 	 ((S\NP)\(S\NP))/NP 	 2 	 climbed from
14 	 13 	 ((S\NP)\(S\NP))/NP 	 3 	 $ to
16 	 14 	 N/N[num] 	 1 	 million $
16 	 15 	 N/N 	 1 	 million 265
20 	 13 	 ((S\NP)\(S\NP))/NP 	 3 	 cents to
20 	 19 	 N/N 	 1 	 cents 80
20 	 21 	 (NP\NP)/N 	 1 	 cents a
22 	 21 	 (NP\NP)/N 	 2 	 share a
25 	 24 	 ((S\NP)\(S\NP))/NP 	 3 	 $ from
25 	 35 	 (NP\NP)/NP 	 1 	 $ in
27 	 25 	 N/N[num] 	 1 	 million $
27 	 26 	 N/N 	 1 	 million 240
31 	 24 	 ((S\NP)\(S\NP))/NP 	 3 	 cents from
31 	 30 	 N/N 	 1 	 cents 71
31 	 32 	 (NP\NP)/N 	 1 	 cents a
31 	 35 	 (NP\NP)/NP 	 1 	 cents in
33 	 32 	 (NP\NP)/N 	 2 	 share a
38 	 35 	 (NP\NP)/NP 	 2 	 period in
38 	 36 	 NP[nb]/N 	 1 	 period the
38 	 37 	 N/N 	 1 	 period year-earlier
<\s>
<s id="wsj_1156.3"> 10
0 	 1 	 S[dcl]\NP 	 1 	 Sales rose
1 	 2 	 ((S\NP)\(S\NP))/NP 	 2 	 rose to
1 	 6 	 ((S\NP)\(S\NP))/NP 	 2 	 rose from
3 	 2 	 ((S\NP)\(S\NP))/NP 	 3 	 $ to
5 	 3 	 N/N[num] 	 1 	 billion $
5 	 4 	 N/N 	 1 	 billion 2.45
7 	 6 	 ((S\NP)\(S\NP))/NP 	 3 	 $ from
9 	 7 	 N/N[num] 	 1 	 billion $
9 	 8 	 N/N 	 1 	 billion 2.2
<\s>
<s id="wsj_1156.4"> 14
3 	 0 	 NP[nb]/N 	 1 	 earnings The
3 	 1 	 N/N 	 1 	 earnings year-ago
3 	 2 	 N/N 	 1 	 earnings per-share
3 	 4 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 earnings are
3 	 5 	 (S[pss]\NP)/(S[to]\NP) 	 1 	 earnings adjusted <XB>
3 	 7 	 (S[b]\NP)/NP 	 1 	 earnings reflect <XB>
5 	 4 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 adjusted are
6 	 5 	 (S[pss]\NP)/(S[to]\NP) 	 2 	 to adjusted
7 	 6 	 (S[to]\NP)/(S[b]\NP) 	 2 	 reflect to
13 	 7 	 (S[b]\NP)/NP 	 2 	 May reflect
13 	 8 	 NP[nb]/N 	 1 	 May a
13 	 9 	 N/N 	 1 	 May 2-for-1
13 	 10 	 N/N 	 1 	 May stock
13 	 11 	 N/N 	 1 	 May split
13 	 12 	 N/N 	 1 	 May last
<\s>
<s id="wsj_1156.5"> 47
2 	 0 	 (S/S)/NP 	 2 	 statement In
2 	 1 	 NP[nb]/N 	 1 	 statement a
6 	 4 	 N/N 	 1 	 Larsen Ralph
6 	 5 	 N/N 	 1 	 Larsen S.
6 	 14 	 (S[dcl]\NP)/S[dcl] 	 1 	 Larsen said
8 	 14 	 (S[dcl]\NP)/S[dcl] 	 1 	 chairman said
12 	 10 	 N/N 	 1 	 officer chief
12 	 11 	 N/N 	 1 	 officer executive
12 	 14 	 (S[dcl]\NP)/S[dcl] 	 1 	 officer said
14 	 0 	 (S/S)/NP 	 1 	 said In
16 	 15 	 NP[nb]/N 	 1 	 company the
16 	 17 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 company was
16 	 18 	 (S[adj]\NP)/PP 	 1 	 company pleased <XB>
17 	 14 	 (S[dcl]\NP)/S[dcl] 	 2 	 was said
17 	 26 	 ((S\NP)\(S\NP))/NP 	 2 	 was in
18 	 17 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 pleased was
19 	 18 	 (S[adj]\NP)/PP 	 2 	 with pleased
23 	 19 	 PP/NP 	 1 	 performance with
23 	 20 	 NP[nb]/N 	 1 	 performance its
23 	 21 	 N/N 	 1 	 performance third-quarter
23 	 22 	 N/N 	 1 	 performance sales
26 	 25 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 in especially
27 	 26 	 ((S\NP)\(S\NP))/NP 	 3 	 light in
27 	 28 	 (NP\NP)/NP 	 1 	 light of
32 	 28 	 (NP\NP)/NP 	 2 	 environment of
32 	 29 	 NP[nb]/N 	 1 	 environment the
32 	 30 	 N/N 	 1 	 environment extremely
32 	 31 	 N/N 	 1 	 environment competitive
32 	 33 	 (NP\NP)/NP 	 1 	 environment in
36 	 33 	 (NP\NP)/NP 	 2 	 markets in
36 	 34 	 N/N 	 1 	 markets domestic
36 	 35 	 N/N 	 1 	 markets consumer
40 	 28 	 (NP\NP)/NP 	 2 	 impact of
40 	 38 	 NP[nb]/N 	 1 	 impact the
40 	 39 	 N/N 	 1 	 impact negative
40 	 41 	 (NP\NP)/NP 	 1 	 impact of
44 	 41 	 (NP\NP)/NP 	 2 	 rates of
44 	 42 	 N/N 	 1 	 rates unfavorable
44 	 43 	 N/N 	 1 	 rates exchange
44 	 45 	 (NP\NP)/N 	 1 	 rates this
46 	 45 	 (NP\NP)/N 	 2 	 quarter this
<\s>
<s id="wsj_1156.6"> 26
2 	 0 	 N/N 	 1 	 Lothson David
2 	 1 	 N/N 	 1 	 Lothson J.
2 	 12 	 (S[dcl]\NP)/S[dcl] 	 1 	 Lothson said
6 	 4 	 NP[nb]/N 	 1 	 analyst an
6 	 5 	 N/N 	 1 	 analyst industry
6 	 7 	 (NP\NP)/NP 	 1 	 analyst for
6 	 12 	 (S[dcl]\NP)/S[dcl] 	 1 	 analyst said
10 	 7 	 (NP\NP)/NP 	 2 	 Inc. for
10 	 8 	 N/N 	 1 	 Inc. PaineWebber
10 	 9 	 N/N 	 1 	 Inc. Group
15 	 13 	 N/N 	 1 	 Johnson Johnson
15 	 14 	 N/N 	 1 	 Johnson &
15 	 16 	 (NP[nb]/N)\NP 	 2 	 Johnson 's
17 	 16 	 (NP[nb]/N)\NP 	 1 	 results 's
17 	 19 	 (S[dcl]\NP)/NP 	 1 	 results exceeded
19 	 12 	 (S[dcl]\NP)/S[dcl] 	 2 	 exceeded said
19 	 18 	 (S\NP)/(S\NP) 	 2 	 exceeded slightly
21 	 19 	 (S[dcl]\NP)/NP 	 2 	 expectations exceeded
21 	 20 	 NP[nb]/N 	 1 	 expectations his
21 	 22 	 (NP\NP)/NP 	 1 	 expectations for
25 	 22 	 (NP\NP)/NP 	 2 	 quarter for
25 	 23 	 NP[nb]/N 	 1 	 quarter the
25 	 24 	 N/N 	 1 	 quarter third
<\s>
<s id="wsj_1156.7"> 19
6 	 0 	 (S/S)/NP 	 2 	 trading In
6 	 1 	 N/N 	 1 	 trading New
6 	 2 	 N/N 	 1 	 trading York
6 	 3 	 N/N 	 1 	 trading Stock
6 	 4 	 N/N 	 1 	 trading Exchange
6 	 5 	 N/N 	 1 	 trading composite
12 	 9 	 N/N 	 1 	 shares Johnson
12 	 10 	 N/N 	 1 	 shares &
12 	 11 	 N/N 	 1 	 shares Johnson
12 	 13 	 S[dcl]\NP 	 1 	 shares fell
13 	 0 	 (S/S)/NP 	 1 	 fell In
13 	 7 	 S/S 	 1 	 fell yesterday
13 	 15 	 (S\NP)\(S\NP) 	 2 	 fell cents
13 	 16 	 ((S\NP)\(S\NP))/NP 	 2 	 fell to
15 	 14 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 cents 37.5
17 	 16 	 ((S\NP)\(S\NP))/NP 	 3 	 $ to
18 	 17 	 N/N[num] 	 1 	 54.625 $
<\s>
<s id="wsj_1156.8"> 20
1 	 0 	 N/N 	 1 	 Larsen Mr.
1 	 2 	 (S[dcl]\NP)/NP 	 1 	 Larsen noted
5 	 2 	 (S[dcl]\NP)/NP 	 2 	 growth noted
5 	 3 	 N/N 	 1 	 growth substantial
5 	 4 	 N/N 	 1 	 growth sales
5 	 6 	 (NP\NP)/NP 	 1 	 growth for
9 	 8 	 (N/N)/(N/N) 	 2 	 introduced recently
13 	 6 	 (NP\NP)/NP 	 2 	 lens for
13 	 7 	 NP[nb]/N 	 1 	 lens the
13 	 9 	 N/N 	 1 	 lens introduced
13 	 10 	 N/N 	 1 	 lens Acuvue
13 	 11 	 N/N 	 1 	 lens disposable
13 	 12 	 N/N 	 1 	 lens contact
15 	 6 	 (NP\NP)/NP 	 2 	 Hismanal for
19 	 6 	 (NP\NP)/NP 	 2 	 antihistamine for
19 	 17 	 NP[nb]/N 	 1 	 antihistamine a
19 	 18 	 N/N 	 1 	 antihistamine once-a-day
<\s>
<s id="wsj_1156.9"> 23
0 	 2 	 S[pss]\NP 	 1 	 Eprex used <XB>
0 	 17 	 S[dcl]\NP 	 1 	 Eprex did
2 	 3 	 ((S\NP)\(S\NP))/NP 	 2 	 used by
5 	 3 	 ((S\NP)\(S\NP))/NP 	 3 	 patients by
5 	 4 	 N/N 	 1 	 patients dialysis
5 	 6 	 (NP\NP)/(S[dcl]\NP) 	 1 	 patients who
5 	 7 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 patients are <XB>
5 	 8 	 S[adj]\NP 	 1 	 patients anemic <XB>
7 	 6 	 (NP\NP)/(S[dcl]\NP) 	 2 	 are who
8 	 7 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 anemic are
11 	 17 	 S[dcl]\NP 	 1 	 Prepulsid did
15 	 13 	 NP[nb]/N 	 1 	 drug a
15 	 14 	 N/N 	 1 	 drug gastro-intestinal
15 	 17 	 S[dcl]\NP 	 1 	 drug did
17 	 18 	 (S\NP)\(S\NP) 	 2 	 did well
17 	 19 	 (S\NP)\(S\NP) 	 2 	 did overseas
17 	 22 	 (S[dcl]\S[dcl])\NP 	 1 	 did said
21 	 22 	 (S[dcl]\S[dcl])\NP 	 2 	 he said
<\s>
<s id="wsj_1156.10"> 33
3 	 0 	 (S/S)/NP 	 2 	 controls Despite
3 	 1 	 N/N 	 1 	 controls health-care
3 	 2 	 N/N 	 1 	 controls cost
5 	 0 	 (S/S)/NP 	 2 	 programs Despite
7 	 6 	 (S[to]\NP)/(S[b]\NP) 	 2 	 hold to
7 	 8 	 (S\NP)\(S\NP) 	 2 	 hold down
9 	 7 	 (S[b]\NP)/NP 	 2 	 inventory hold
13 	 11 	 NP[nb]/N 	 1 	 division the
13 	 12 	 N/N 	 1 	 division professional
13 	 15 	 (NP\NP)/(S[dcl]\NP) 	 1 	 division which
13 	 16 	 (S[dcl]\NP)/NP 	 1 	 division makes <XB>
13 	 25 	 (S[dcl]\NP)/NP 	 1 	 division achieved
16 	 15 	 (NP\NP)/(S[dcl]\NP) 	 2 	 makes which
17 	 16 	 (S[dcl]\NP)/NP 	 2 	 products makes
17 	 18 	 (NP\NP)/NP 	 1 	 products including
19 	 18 	 (NP\NP)/NP 	 2 	 sutures including
23 	 18 	 (NP\NP)/NP 	 2 	 equipment including
23 	 21 	 N/N 	 1 	 equipment surgical
23 	 22 	 N/N 	 1 	 equipment stapling
25 	 0 	 (S/S)/NP 	 1 	 achieved Despite
25 	 32 	 (S[dcl]\S[dcl])\NP 	 1 	 achieved said
27 	 25 	 (S[dcl]\NP)/NP 	 2 	 growth achieved
27 	 26 	 N/N 	 1 	 growth solid
31 	 29 	 N/N 	 1 	 Johnson Johnson
31 	 30 	 N/N 	 1 	 Johnson &
31 	 32 	 (S[dcl]\S[dcl])\NP 	 2 	 Johnson said
<\s>
<s id="wsj_1156.11"> 19
3 	 1 	 N/N 	 1 	 sales domestic
3 	 2 	 N/N 	 1 	 sales consumer
3 	 4 	 S[dcl]\NP 	 1 	 sales slipped
4 	 0 	 S/S 	 1 	 slipped But
4 	 6 	 (S\NP)\(S\NP) 	 2 	 slipped %
4 	 7 	 ((S\NP)\(S\NP))/NP 	 2 	 slipped for
4 	 11 	 ((S\NP)\(S\NP))/NP 	 2 	 slipped to
4 	 15 	 ((S\NP)\(S\NP))/NP 	 2 	 slipped from
6 	 5 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 % 1.2
9 	 7 	 ((S\NP)\(S\NP))/NP 	 3 	 quarter for
9 	 8 	 NP[nb]/N 	 1 	 quarter the
12 	 11 	 ((S\NP)\(S\NP))/NP 	 3 	 $ to
14 	 12 	 N/N[num] 	 1 	 million $
14 	 13 	 N/N 	 1 	 million 490
16 	 15 	 ((S\NP)\(S\NP))/NP 	 3 	 $ from
18 	 16 	 N/N[num] 	 1 	 million $
18 	 17 	 N/N 	 1 	 million 496
<\s>
<s id="wsj_1156.12"> 27
1 	 0 	 NP[nb]/N 	 1 	 company The
1 	 2 	 (S[dcl]\NP)/NP 	 1 	 company cited
3 	 2 	 (S[dcl]\NP)/NP 	 2 	 softness cited
3 	 4 	 (NP\NP)/NP 	 1 	 softness in
3 	 13 	 NP\NP 	 1 	 softness as
3 	 14 	 NP\NP 	 1 	 softness well
3 	 15 	 NP\NP 	 1 	 softness as
3 	 16 	 (NP\NP)/N 	 1 	 softness the
7 	 4 	 (NP\NP)/NP 	 2 	 health in
7 	 5 	 NP[nb]/N 	 1 	 health the
7 	 6 	 N/N 	 1 	 health retail
11 	 4 	 (NP\NP)/NP 	 2 	 category in
11 	 5 	 NP[nb]/N 	 1 	 category the
11 	 6 	 N/N 	 1 	 category retail
11 	 9 	 N/N 	 1 	 category beauty
11 	 10 	 N/N 	 1 	 category aids
16 	 19 	 ((NP\NP)\(NP\NP))/NP 	 2 	 the in
18 	 16 	 (NP\NP)/N 	 2 	 competition the
18 	 17 	 N/N 	 1 	 competition intense
21 	 20 	 NP[nb]/N 	 1 	 company the
21 	 22 	 (NP[nb]/N)\NP 	 2 	 company 's
26 	 19 	 ((NP\NP)\(NP\NP))/NP 	 3 	 line in
26 	 22 	 (NP[nb]/N)\NP 	 1 	 line 's
26 	 23 	 N/N 	 1 	 line sanitary
26 	 24 	 N/N 	 1 	 line protection
26 	 25 	 N/N 	 1 	 line product
<\s>
<s id="wsj_1156.13"> 25
1 	 0 	 N/N 	 1 	 sales Overseas
1 	 2 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 sales were
1 	 3 	 S[adj]\NP 	 1 	 sales stronger <XB>
2 	 6 	 ((S\NP)\(S\NP))/PP 	 2 	 were because
2 	 24 	 (S[dcl]\S[dcl])\NP 	 1 	 were said
3 	 2 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 stronger were
6 	 5 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 because principally
7 	 6 	 ((S\NP)\(S\NP))/PP 	 3 	 of because
9 	 7 	 PP/NP 	 1 	 rebound of
9 	 8 	 NP[nb]/N 	 1 	 rebound a
9 	 10 	 (NP\NP)/NP 	 1 	 rebound in
11 	 10 	 (NP\NP)/NP 	 2 	 Brazil in
11 	 13 	 (NP\NP)/S[dcl] 	 1 	 Brazil where
15 	 14 	 N/N 	 1 	 turmoil economic
15 	 16 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 turmoil had
15 	 17 	 (S[pt]\NP)/NP 	 1 	 turmoil hurt <XB>
16 	 13 	 (NP\NP)/S[dcl] 	 2 	 had where
17 	 16 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 hurt had
19 	 17 	 (S[pt]\NP)/NP 	 2 	 results hurt
19 	 18 	 N/N 	 1 	 results year-earlier
23 	 21 	 N/N 	 1 	 Johnson Johnson
23 	 22 	 N/N 	 1 	 Johnson &
23 	 24 	 (S[dcl]\S[dcl])\NP 	 2 	 Johnson said
<\s>
<s id="wsj_1156.14"> 31
1 	 0 	 N/N 	 1 	 Lothson Mr.
1 	 2 	 (NP\NP)/NP 	 1 	 Lothson of
1 	 4 	 (S[dcl]\NP)/S[dcl] 	 1 	 Lothson said
3 	 2 	 (NP\NP)/NP 	 2 	 PaineWebber of
6 	 5 	 NP[nb]/N 	 1 	 company the
6 	 7 	 (NP[nb]/N)\NP 	 2 	 company 's
9 	 7 	 (NP[nb]/N)\NP 	 1 	 pace 's
9 	 8 	 N/N 	 1 	 pace sales
9 	 10 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 pace has
9 	 12 	 S[ng]\NP 	 1 	 pace picking <XB>
10 	 4 	 (S[dcl]\NP)/S[dcl] 	 2 	 has said
11 	 10 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been has
12 	 11 	 (S[pt]\NP)/(S[ng]\NP) 	 2 	 picking been
12 	 13 	 (S\NP)\(S\NP) 	 2 	 picking up
12 	 15 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 picking because
15 	 14 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 because largely
17 	 16 	 NP[nb]/N 	 1 	 effect the
17 	 18 	 (NP\NP)/NP 	 1 	 effect of
17 	 22 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 effect has
17 	 24 	 S[ng]\NP 	 1 	 effect easing <XB>
21 	 18 	 (NP\NP)/NP 	 2 	 rates of
21 	 19 	 N/N 	 1 	 rates unfavorable
21 	 20 	 N/N 	 1 	 rates exchange
22 	 15 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 has because
23 	 22 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been has
24 	 23 	 (S[pt]\NP)/(S[ng]\NP) 	 2 	 easing been
24 	 25 	 ((S\NP)\(S\NP))/NP 	 2 	 easing --
27 	 25 	 ((S\NP)\(S\NP))/NP 	 3 	 pattern --
27 	 26 	 NP[nb]/N 	 1 	 pattern a
27 	 28 	 S[ng]\NP 	 1 	 pattern continuing <XB>
28 	 29 	 ((S\NP)\(S\NP))/N 	 2 	 continuing this
30 	 29 	 ((S\NP)\(S\NP))/N 	 3 	 quarter this
<\s>
<s id="wsj_1156.15"> 21
0 	 1 	 (S[dcl]\NP)/S[em] 	 1 	 He cautioned
1 	 3 	 (S\NP)\(S\NP) 	 2 	 cautioned however
5 	 1 	 (S[dcl]\NP)/S[em] 	 2 	 that cautioned
9 	 6 	 NP[nb]/N 	 1 	 comparison a
9 	 7 	 N/N 	 1 	 comparison tough
9 	 8 	 N/N 	 1 	 comparison tax-rate
9 	 10 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 comparison may
9 	 11 	 (S[b]\NP)/NP 	 1 	 comparison slow <XB>
10 	 5 	 S[em]/S[dcl] 	 1 	 may that
11 	 10 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 slow may
13 	 12 	 NP[nb]/N 	 1 	 company the
13 	 14 	 (NP[nb]/N)\NP 	 2 	 company 's
16 	 11 	 (S[b]\NP)/NP 	 2 	 growth slow
16 	 14 	 (NP[nb]/N)\NP 	 1 	 growth 's
16 	 15 	 N/N 	 1 	 growth earnings
16 	 17 	 (NP\NP)/NP 	 1 	 growth for
20 	 17 	 (NP\NP)/NP 	 2 	 quarter for
20 	 18 	 NP[nb]/N 	 1 	 quarter the
20 	 19 	 N/N 	 1 	 quarter current
<\s>
<s id="wsj_1156.16"> 20
2 	 1 	 N/N 	 1 	 year last
2 	 3 	 (NP[nb]/N)\NP 	 2 	 year 's
5 	 0 	 (S/S)/NP 	 2 	 quarter For
5 	 3 	 (NP[nb]/N)\NP 	 1 	 quarter 's
5 	 4 	 N/N 	 1 	 quarter fourth
8 	 7 	 NP[nb]/N 	 1 	 company the
8 	 9 	 (NP[nb]/N)\NP 	 2 	 company 's
11 	 9 	 (NP[nb]/N)\NP 	 1 	 rate 's
11 	 10 	 N/N 	 1 	 rate tax
11 	 12 	 (S[dcl]\NP)/NP 	 1 	 rate was
12 	 0 	 (S/S)/NP 	 1 	 was For
12 	 19 	 (S[dcl]\S[dcl])\NP 	 1 	 was said
13 	 14 	 ((N/N)/(N/N))\(S[adj]\NP) 	 3 	 less than
15 	 14 	 ((N/N)/(N/N))\(S[adj]\NP) 	 2 	 20 than
16 	 12 	 (S[dcl]\NP)/NP 	 2 	 % was
16 	 15 	 N/N 	 1 	 % 20
18 	 19 	 (S[dcl]\S[dcl])\NP 	 2 	 he said
<\s>
<s id="wsj_1156.17"> 31
3 	 1 	 NP[nb]/N 	 1 	 period the
3 	 2 	 N/N 	 1 	 period third
3 	 4 	 (S[dcl]\NP)/NP 	 1 	 period contained
4 	 0 	 (S/S)/S[dcl] 	 2 	 contained While
7 	 4 	 (S[dcl]\NP)/NP 	 2 	 surprises contained
7 	 5 	 NP[nb]/N 	 1 	 surprises no
7 	 6 	 N/N 	 1 	 surprises major
10 	 9 	 N/N 	 1 	 Lothson Mr.
10 	 11 	 (S[dcl]\NP)/S[dcl] 	 1 	 Lothson said
14 	 13 	 NP[nb]/N 	 1 	 results the
14 	 15 	 (S[dcl]\NP)/S[qem] 	 1 	 results show
15 	 0 	 (S/S)/S[dcl] 	 1 	 show While
15 	 11 	 (S[dcl]\NP)/S[dcl] 	 2 	 show said <XU>
16 	 15 	 (S[dcl]\NP)/S[qem] 	 2 	 how show
17 	 16 	 (S[qem]/(S[dcl]/(S[adj]\NP)))/(S[adj]\NP) 	 2 	 sensitive how
19 	 18 	 NP[nb]/N 	 1 	 multinationals the
19 	 20 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 multinationals can
20 	 16 	 (S[qem]/(S[dcl]/(S[adj]\NP)))/(S[adj]\NP) 	 1 	 can how
21 	 20 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be can
21 	 22 	 ((S\NP)\(S\NP))/NP 	 2 	 be to
23 	 22 	 ((S\NP)\(S\NP))/NP 	 3 	 developments to
23 	 24 	 (NP\NP)/NP 	 1 	 developments in
27 	 24 	 (NP\NP)/NP 	 2 	 country in
27 	 25 	 NP[nb]/N 	 1 	 country a
27 	 26 	 N/N 	 1 	 country single
27 	 28 	 NP\NP 	 1 	 country such
27 	 29 	 NP\NP 	 1 	 country as
27 	 30 	 NP\NP 	 1 	 country Brazil
<\s>
<s id="wsj_1156.18"> 12
0 	 2 	 (S[dcl]\NP)/S[qem] 	 1 	 He questioned
2 	 1 	 (S\NP)/(S\NP) 	 2 	 questioned also
3 	 2 	 (S[dcl]\NP)/S[qem] 	 2 	 whether questioned
5 	 4 	 N/N 	 1 	 gains recent
5 	 6 	 (NP\NP)/NP 	 1 	 gains in
5 	 9 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 gains can
5 	 11 	 S[pss]\NP 	 1 	 gains sustained <XB>
8 	 6 	 (NP\NP)/NP 	 2 	 country in
8 	 7 	 NP[nb]/N 	 1 	 country that
9 	 3 	 S[qem]/S[dcl] 	 1 	 can whether
10 	 9 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be can
11 	 10 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 sustained be
<\s>
<s id="wsj_1156.19"> 12
2 	 0 	 NP[nb]/N 	 1 	 issues The
2 	 1 	 N/N 	 1 	 issues following
2 	 3 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 issues were
2 	 5 	 (S[pss]\NP)/PP 	 1 	 issues filed <XB>
3 	 4 	 (S\NP)\(S\NP) 	 2 	 were recently
5 	 3 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 filed were
6 	 5 	 (S[pss]\NP)/PP 	 2 	 with filed
8 	 6 	 PP/NP 	 1 	 Securities with
8 	 7 	 NP[nb]/N 	 1 	 Securities the
11 	 6 	 PP/NP 	 1 	 Commission with
11 	 7 	 NP[nb]/N 	 1 	 Commission the
11 	 10 	 N/N 	 1 	 Commission Exchange
<\s>
<s id="wsj_1156.20"> 17
2 	 0 	 N/N 	 1 	 Corp. Bergen
2 	 1 	 N/N 	 1 	 Corp. Brunswig
2 	 12 	 (NP\NP)/NP 	 1 	 Corp. via
5 	 4 	 N/N 	 1 	 offering proposed
5 	 6 	 (NP\NP)/NP 	 1 	 offering of
5 	 12 	 (NP\NP)/NP 	 1 	 offering via
10 	 6 	 (NP\NP)/NP 	 2 	 notes of
10 	 7 	 N/N 	 1 	 notes liquid
10 	 8 	 N/N 	 1 	 notes yield
10 	 9 	 N/N 	 1 	 notes option
16 	 12 	 (NP\NP)/NP 	 2 	 Markets via
16 	 13 	 N/N 	 1 	 Markets Merrill
16 	 14 	 N/N 	 1 	 Markets Lynch
16 	 15 	 N/N 	 1 	 Markets Capital
<\s>
<s id="wsj_1156.21"> 15
3 	 0 	 N/N 	 1 	 Inc. Columbia
3 	 1 	 N/N 	 1 	 Inc. Gas
3 	 2 	 N/N 	 1 	 Inc. System
6 	 5 	 N/N 	 1 	 offering shelf
6 	 7 	 (NP\NP)/NP 	 1 	 offering of
10 	 7 	 (NP\NP)/NP 	 2 	 $ of
10 	 8 	 N/N 	 1 	 $ up
10 	 9 	 N/N 	 1 	 $ to
10 	 13 	 (NP\NP)/NP 	 1 	 $ of
12 	 10 	 N/N[num] 	 1 	 million $
12 	 11 	 N/N 	 1 	 million 200
14 	 13 	 (NP\NP)/NP 	 2 	 debentures of
<\s>
<s id="wsj_1156.23"> 16
2 	 0 	 N/N 	 1 	 Inc. TeleVideo
2 	 1 	 N/N 	 1 	 Inc. Systems
5 	 4 	 N/N 	 1 	 offering proposed
5 	 6 	 (NP\NP)/NP 	 1 	 offering of
9 	 6 	 (NP\NP)/NP 	 2 	 shares of
9 	 7 	 N/N 	 1 	 shares 1,853,735
9 	 8 	 N/N 	 1 	 shares common
12 	 11 	 (S[to]\NP)/(S[b]\NP) 	 2 	 be to
13 	 12 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 sold be
13 	 14 	 ((S\NP)\(S\NP))/NP 	 2 	 sold by
15 	 14 	 ((S\NP)\(S\NP))/NP 	 3 	 holders by
<\s>
